19 Stocks Making Big M&A News and Rumors This Week

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Here’s your Cheat Sheet to this week’s top mergers and acquisition news:

Markets are at 5-year highs! Discover the best stocks to own. Click here for our fresh Feature Stock Pick now!

Cisco Systems (NASDAQ:CSCO): Current price $20.90

On Monday, the company announced the purchase of the privately-held SolveDirect, which is headquartered in Vienna. The acquired firm provides innovative, cloud-delivered services management integration software and services. Cisco’s Hilton Romansky commented on the company blog that, “The move towards multi-sourcing and cloud services is accelerating the development of large ecosystems of companies – from enterprise IT and manufacturing, to SaaS providers – that need to share data in a secure and scalable way.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.


Yahoo! (NASDAQ:YHOO): Current price $23.57

Early on Monday, Yahoo reported that it had purchased the news reading application Summly, along with its very young entrepreneur Nick D’Aloisio. The buyer said it will close down the actual app and use the algorithmic summation tech that the 17-year-old D’Aloisio built with a small team of five throughout its products. The actual purchase was not divulged, but a number of sources told Kara Swisher that Yahoo paid $30 million, 10 percent in stock and 90 percent in cash, to buy the London-based Apple smartphone application.

It was last week when Amir Efrati and Sam Shechner at The Wall Street Journal said that Yahoo was nearing the acquisition of a controlling interest in the YouTube version for Europe, Dailymotion, valued in the ballpark of $300 million. BusinessInsider says that “we cannot confirm that the deal is done – but we can say that two separate sources, one, close to Yahoo, another, involved in the deals space, believe the deal is as good as done, and talked to us as though it was.”

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.


Shire (NASDAQ: SHPG): Current price $91.37

Shire announced Monday that it will buy SARcode Bioscience, a privately-held biopharmaceutical firm based in Brisbane, California. This acquisition reinforces Shire’s presence in the ophthalmology therapeutic category and brings a new phase 3 compound, Lifitegrast, currently under development for the signs and symptoms of dry eye disease, into Shire’s lineup. Shire expects to introduce the drug in the United States as early as 2016, pending a positive outcome of the phase 3 clinical development program and regulatory approvals. The firm is buying the world rights to Lifitegrast and will examine an appropriate regulatory filing strategy for markets outside of the U.S.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business